Page last updated: 2024-09-02

fingolimod hydrochloride and Central Retinal Edema, Cystoid

fingolimod hydrochloride has been researched along with Central Retinal Edema, Cystoid in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (3.23)29.6817
2010's24 (77.42)24.3611
2020's6 (19.35)2.80

Authors

AuthorsStudies
Asahi, M; Culp, C; Foos, WF; Patronas, M1
Andersen, CU; Hilt, C; Nørgaard, TL1
Goh, LY; Harvey, JP; Jackson, TL; Kirthi, V; Silber, E1
Bisecco, A; Capuano, R; d'Ambrosio, A; Filippi, M; Gallo, A; Gesualdo, C; Lanza, M; Leocani, L; Maimone, D; Marino, C; Rodegher, M; Rossi, S; Simonelli, F; Tedeschi, G1
Karakosta, C; Kourentis, C1
Gillam, M; Richardson, T1
Aslam, T; Jasani, KM; Rog, D; Sharaf, N1
Dick, HB; Elling, M; Kakkassery, V; Kleiter, I; Rehrmann, J; Schelenz, D; Schöllhammer, J1
Annunziata, P; Capozzoli, M; Fruschelli, M; Gelmi, MC; Masi, G1
Collins, W; Francis, G; Jager, RD; Jampol, LM; Reder, AT; Tang, D; Zarbin, MA; Zhang, X1
Chang, A; Chui, J; Herkes, GK1
Almeida, DR; Belliveau, MJ; Dorrepaal, SJ; Gale, JS; Minuk, A1
Georgakopoulos, CD; Georgalas, I; Makri, OE1
Asensio-Sánchez, VM; Ramoa-Osorio, R; Trujillo-Guzmán, L1
Francis, CE1
Chen, C; Cugati, S; Lee, A; Thoo, S1
Coote, M; Gaskin, JC1
Aktas, O; Finis, D; Geerling, G; Guthoff, R; Harmel, J; Hartung, HP; Ringelstein, M; Schröder, K1
Saida, K; Ueda, N1
Akamatsu, M; Akiyama, H; Hara, D; Hasegawa, Y; Ogura, H; Shinohara, K; Suzuki, Y1
Brescia Morra, V; Brogi, D; Comi, G; Guidi, L; Laroni, A; Lugaresi, A; Mancardi, GL; Pozzilli, C; Raimondi, D; Turrini, R; Uccelli, A1
Cifuentes-Canorea, P; Nieves-Moreno, M; Sáenz-Francés, F; Santos-Bueso, E1
Frank, B; Osmanovic, A; Pars, K; Pielen, A; Pul, R; Schmalstieg, H; Schwenkenbecher, P; Skripuletz, T; Stangel, M; Sühs, KW; Yildiz, Ö1
Agoropoulou, C; Burtin, P; Calabresi, P; Hohlfeld, R; Kappos, L; Leyk, M; O'Connor, P; Polman, C; Radue, EW; Selmaj, K; Zhang-Auberson, L1
Weinstock-Guttman, B; Yeh, EA1
Bryan, JS; Turaka, K1
Bhatti, MT; Jain, N1
Bermel, RA; Cohen, JA; Hara-Cleaver, C; Ontaneda, D; Rudick, RA1
Huggins, A; Sergott, RC1
Afshar, AR; Fernandes, JK; Hariprasad, SM; Ksiazek, SM; Patel, RD; Reder, AT; Sheth, VS1
Almony, A; Blinder, KJ; Brennan, DC; Saab, G; Schuessler, R1

Reviews

5 review(s) available for fingolimod hydrochloride and Central Retinal Edema, Cystoid

ArticleYear
Fingolimod-associated macular edema: A case report of late onset.
    European journal of ophthalmology, 2022, Volume: 32, Issue:4

    Topics: Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Tomography, Optical Coherence; Visual Acuity

2022
Drug-induced macular edema.
    Drugs, 2013, Volume: 73, Issue:8

    Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Fingolimod Hydrochloride; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Interferons; Macular Edema; Niacin; Ophthalmic Solutions; Propylene Glycols; Sphingosine; Tamoxifen; Taxoids; Thiazolidinediones; Timolol

2013
Visual issues in multiple sclerosis.
    Physical medicine and rehabilitation clinics of North America, 2013, Volume: 24, Issue:4

    Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis; Neuromyelitis Optica; Nystagmus, Pathologic; Ocular Motility Disorders; Optic Neuritis; Prognosis; Propylene Glycols; Sphingosine; Uveitis

2013
Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.
    Advances in therapy, 2011, Volume: 28, Issue:4

    Topics: Activities of Daily Living; Administration, Oral; Bradycardia; Central Nervous System; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Progression; Female; Fingolimod Hydrochloride; Herpesviridae Infections; Humans; Immunosuppressive Agents; Macular Edema; Male; Multiple Sclerosis, Relapsing-Remitting; Neuroimmunomodulation; Neurologic Examination; Propylene Glycols; Receptors, Lysosphingolipid; Recurrence; Sphingosine; Treatment Outcome; Young Adult

2011
Fingolimod-associated macular edema: incidence, detection, and management.
    Neurology, 2012, Feb-28, Volume: 78, Issue:9

    Topics: Fingolimod Hydrochloride; Humans; Macular Edema; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine

2012

Trials

4 trial(s) available for fingolimod hydrochloride and Central Retinal Edema, Cystoid

ArticleYear
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
    Ophthalmology, 2013, Volume: 120, Issue:7

    Topics: Adolescent; Adult; Double-Blind Method; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Ophthalmoscopy; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity; Young Adult

2013
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:1

    Topics: Adult; Female; Fingolimod Hydrochloride; Headache; Humans; Immunosuppressive Agents; Infections; Italy; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Treatment Outcome

2017
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
    The New England journal of medicine, 2010, Feb-04, Volume: 362, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Arrhythmias, Cardiac; Brain; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Fingolimod Hydrochloride; Herpesviridae Infections; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Liver Function Tests; Macular Edema; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Young Adult

2010
Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:1

    Topics: Cyclosporine; Drug Therapy, Combination; Fingolimod Hydrochloride; Fluorescein Angiography; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Macular Edema; Prednisone; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Transplantation, Homologous

2008

Other Studies

22 other study(ies) available for fingolimod hydrochloride and Central Retinal Edema, Cystoid

ArticleYear
Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema.
    BMJ case reports, 2022, Nov-11, Volume: 15, Issue:11

    Topics: Diabetes Mellitus; Diabetic Retinopathy; Fingolimod Hydrochloride; Fluoresceins; Humans; Macular Edema; Visual Acuity

2022
Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod.
    Basic & clinical pharmacology & toxicology, 2020, Volume: 126, Issue:6

    Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Macula Lutea; Macular Edema; Male; Multiple Sclerosis; Retina; Tomography, Optical Coherence; Visual Acuity

2020
Real-world incidence of fingolimod-associated macular oedema.
    Multiple sclerosis and related disorders, 2020, Volume: 42

    Topics: Adult; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Incidence; London; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Tomography, Optical Coherence

2020
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:2

    Topics: Fingolimod Hydrochloride; Humans; Macular Edema; Multiple Sclerosis; Tomography, Optical Coherence; Visual Acuity

2021
Bilateral fingolimod-associated macular oedema development after cataract surgery.
    BMJ case reports, 2021, Jun-04, Volume: 14, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extraction; Fingolimod Hydrochloride; Humans; Macular Edema

2021
Fingolimod-associated macular oedema.
    BMJ case reports, 2017, Jun-15, Volume: 2017

    Topics: Anti-Inflammatory Agents; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Prednisolone; Tomography, Optical Coherence

2017
[Early onset of fingolimod-associated macular edema].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2018, Volume: 115, Issue:5

    Topics: Female; Fingolimod Hydrochloride; Germany; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting

2018
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis.
    International ophthalmology, 2019, Volume: 39, Issue:4

    Topics: Adult; Analysis of Variance; Female; Fingolimod Hydrochloride; Fovea Centralis; Humans; Immunosuppressive Agents; Macula Lutea; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Tomography, Optical Coherence

2019
Management of fingolimod-associated macular edema.
    JAMA ophthalmology, 2013, Volume: 131, Issue:5

    Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Ketorolac Tromethamine; Macular Edema; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity

2013
Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
    JAMA ophthalmology, 2013, Volume: 131, Issue:6

    Topics: Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intraocular; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone

2013
[Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
    Archivos de la Sociedad Espanola de Oftalmologia, 2014, Volume: 89, Issue:3

    Topics: Adult; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis; Propylene Glycols; Sphingosine

2014
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2015, Volume: 21, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis; Triamcinolone

2015
Postoperative cystoid macular oedema in a patient on fingolimod.
    BMJ case reports, 2015, May-12, Volume: 2015

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Diclofenac; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Ophthalmic Solutions; Prednisolone

2015
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
    Multiple sclerosis and related disorders, 2015, Volume: 4, Issue:5

    Topics: Acetazolamide; Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis, Relapsing-Remitting; Optic Neuritis; Visual Acuity; Young Adult

2015
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
    BMC ophthalmology, 2015, Oct-19, Volume: 15

    Topics: Adult; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Male; Multiple Sclerosis; Retinal Hemorrhage; Tomography, Optical Coherence

2015
Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report.
    Medicine, 2016, Volume: 95, Issue:29

    Topics: Aged; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis, Relapsing-Remitting

2016
Early and recurrent macular oedema in a patient treated with fingolimod.
    Neurologia, 2019, Volume: 34, Issue:3

    Topics: Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Tomography, Optical Coherence

2019
Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?
    International journal of molecular sciences, 2016, Dec-14, Volume: 17, Issue:12

    Topics: Adult; Clinical Trials as Topic; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Multiple Sclerosis; Tomography, Optical Coherence

2016
Does fingolimod in multiple sclerosis patients cause macular edema?
    Journal of neurology, 2012, Volume: 259, Issue:2

    Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine; Tomography, Optical Coherence

2012
Early tolerability and safety of fingolimod in clinical practice.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Adult; Bradycardia; Chest Pain; Drug Substitution; Female; Fingolimod Hydrochloride; Headache; Humans; Hypertension; Lymphopenia; Macular Edema; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nausea; Patient Acceptance of Health Care; Product Surveillance, Postmarketing; Propylene Glycols; Retrospective Studies; Sphingosine

2012
Gilenya safety update: cardiac and macula.
    Current opinion in ophthalmology, 2012, Volume: 23, Issue:6

    Topics: Bradycardia; Drug Monitoring; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Macular Edema; Multiple Sclerosis; Propylene Glycols; Sphingosine

2012
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
    JAMA ophthalmology, 2013, Volume: 131, Issue:1

    Topics: Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Macular Edema; Male; Middle Aged; Multiple Sclerosis; Propylene Glycols; Retrospective Studies; Sphingosine; Tomography, Optical Coherence; Visual Acuity

2013
chemdatabank.com